Externally used pharmaceutical composition for treating eruption

Abstract

The invention provides an externally used pharmaceutical composition for treating eruption. The externally used pharmaceutical composition is an externally used preparation prepared by the following active ingredients in parts by weight: 14-26 parts of fructus kochiae, 14-26 parts of fructus cnidii, 14-26 parts of chaulmoogra tree seeds, 14-26 parts of radix sophorae flavescentis, 14-26 parts of smilax glabra, 14-26 parts of cortex dictamni, 8-16 parts of radix lithospermi, and 8-16 parts of herba schizonepetae. The invention further provides a preparation method and applications for the pharmaceutical composition. The pharmaceutical composition can effectively eliminate or greatly relieve the symptoms of eruption diseases such as eczema, prurigo and the like, can eliminate disease source influence of hypersensitivity and the like and heal the primary diseases, and provides a new choice for clinical medicine.

Description

technical field

[0001] The invention relates to an external pharmaceutical composition for treating rash. Background technique

[0002] Rash refers to the symptoms of red or red and white rashes on the skin that are raised above the skin. It is mostly caused by wind-heat, rheumatism, epidemic toxin and other pathogenic factors, which accumulate in the skin. It is common in rubella, measles, milk hemp, skin diseases such as eczema, drug poisoning, prickly heat cancer, scabies, earth wind sores, blood wind sores, blood malnutrition, premenstrual hidden rash, pregnancy rubella, etc. An exogenous febrile disease. Common rashes include eczema, prurigo, and rubella.

[0003] Eczema is an inflammation of the superficial dermis and epidermis caused by a variety of internal and external factors. It is a common allergic and inflammatory skin disease. Features, mainly divided into acute eczema, subacute eczema and chronic eczema three classes. Patients with eczema may have a varie...